Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production (Q81310867)
Jump to navigation
Jump to search
scientific article published on 20 May 2008
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production |
scientific article published on 20 May 2008 |
Statements
Rituximab is effective in the treatment of refractory Churg-Strauss syndrome and is associated with diminished T-cell interleukin-5 production (English)
R J Pepper
M A Fabre
C Pavesio
G Gaskin
D Jayne
C D Pusey